Stephen Squinto, Ph.D.

Position: Co-Founder, Chief Executive Officer, Chair of the Board

Dr. Squinto is an entrepreneur and biotechnology industry veteran with more than 30 years of experience in drug development. He is an executive partner at OrbiMed Advisors, and most recently served as interim chief executive officer at Passage Bio, Inc. Prior to that, he co-founded Alexion Pharmaceuticals, Inc. and served as its executive vice president and chief global operations officer. Earlier in his career, Dr. Squinto held various positions at Regeneron Pharmaceuticals, Inc. and joint academic positions at the Tulane University and LSU Medical Schools.  He is a recipient of numerous honors and awards from academic and professional organizations for his scientific work. Dr. Squinto received his B.A. in Chemistry and Ph.D. in Biochemistry and Biophysics from Loyola University of Chicago.